Praxis Precision Medicines Inc Live Share Price Today, Share Analysis and Chart

Name: Praxis Precision Medicines Inc: Is Infosys Ltd. worth buying?
Item: Praxis Precision Medicines Inc
Rating: 1.48350
Author: Trendlyne DVM scores

about

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal ...

50.54 0.24 (0.48%)

44.96% Fall from 52W High

298.0K

XNAS Volume

XNAS 11 Jul, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

9.5 / 100

Technically Neutral

49.8 / 100

1Yr Price target upside is 96%

12 analysts

Praxis Precision Medicines... Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Praxis Precision Medicines Inc Live Share Price Today, Share Analysis and Chart

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal ...

44.96% Fall from 52W High

SWOT Analysis

Praxis Precision Medicines... Live Price Chart